These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3145868)

  • 1. In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101.
    Barry AL; Aldridge KE; Allen SD; Fuchs PC; Gerlach EH; Jones RN; Pfaller MA
    Eur J Clin Microbiol Infect Dis; 1988 Dec; 7(6):794-8. PubMed ID: 3145868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro activity of the penem, FCE 22101, and tentative interpretive criteria for disc susceptibility tests.
    Barry AL; Jones RN; Thornsberry C
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():17-30. PubMed ID: 2732139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibiotics.
    Wise R; Andrews JM; Danks G
    Antimicrob Agents Chemother; 1983 Dec; 24(6):909-14. PubMed ID: 6607032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative inhibitory and bactericidal activities of FCE 22101 against gram-positive cocci and anaerobes in vitro.
    Maskell JP; Tang T; Asad S; Williams JD
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():65-74. PubMed ID: 2732145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro activity of meropenem imipenem, the penem HRE 664 and ceftazidine against clinical isolates from West Germany.
    Bauernfeind A; Jungwirth R; Schweighart S
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():73-84. PubMed ID: 2509418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in-vitro activity of the penem FCE 22101 against recent European blood culture isolates.
    Dornbusch K; Kronvall G; Göransson E; Mörtsell E
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():43-52. PubMed ID: 2732143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial activity of FCE 22101 against relatively resistant blood culture isolates.
    Qadri SM; Ueno Y; Ellis ME
    Chemotherapy; 1991; 37(1):15-22. PubMed ID: 2013238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in-vitro activity of a novel penem FCE 22101 compared to other beta-lactam antibiotics.
    Neu HC; Chin NX; Labthavikul P
    J Antimicrob Chemother; 1985 Sep; 16(3):305-13. PubMed ID: 2997100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter in vitro evaluation of SM-7338, a new carbapenem.
    Jones RN; Aldridge KE; Allen SD; Barry AL; Fuchs PC; Gerlach EH; Pfaller MA
    Antimicrob Agents Chemother; 1989 Apr; 33(4):562-5. PubMed ID: 2658796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro interaction between the penem FCE 22101 and ceftazidime.
    Barry AL; Jones RN
    Eur J Clin Microbiol Infect Dis; 1988 Dec; 7(6):807-9. PubMed ID: 3145870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro activity of a new penem FCE 22101.
    Hoban DJ
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():53-7. PubMed ID: 2786518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activity of FCE 22101 and synergy studies with other antimicrobial agents.
    Chin NX; Neu HC
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():95-101. PubMed ID: 2786520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
    Krause R; Mittermayer H; Feierl G; Allerberger F; Wendelin I; Hirschl A; Reisinger EC
    Wien Klin Wochenschr; 1999 Jul; 111(14):549-54. PubMed ID: 10467641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activity of FCE 22101 against respiratory tract pathogens with reference to production of beta-lactamases.
    Dornbusch K; Kronvall G; Göransson E; Mörtsell E
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():31-41. PubMed ID: 2786517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.
    Fraenkel CJ; Ullberg M; Bernander S; Ericson E; Larsson P; Rydberg J; Törnqvist E; Melhus A
    Scand J Infect Dis; 2006; 38(10):853-9. PubMed ID: 17008228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z; Kayacan C; Oncul O
    Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid.
    Barry AL; Gavan TL; Jones RN; Ayers LW; Fuchs PC; Gerlach EH; Thornsberry C
    Diagn Microbiol Infect Dis; 1987 May; 7(1):83-7. PubMed ID: 3121242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations.
    Jones RN; Huynh HK; Biedenbach DJ; Fritsche TR; Sader HS
    J Antimicrob Chemother; 2004 Jul; 54(1):144-54. PubMed ID: 15190031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem.
    Asahi Y; Miyazaki S; Yamaguchi K
    Antimicrob Agents Chemother; 1995 May; 39(5):1030-7. PubMed ID: 7625784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.